Form 8-K - Current report:
SEC Accession No. 0001437749-24-030299
Filing Date
2024-10-01
Accepted
2024-10-01 08:00:58
Documents
16
Period of Report
2024-09-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K crvo20240930_8k.htm   iXBRL 8-K 29801
2 EXHIBIT 99.1 ex_728559.htm EX-99.1 11912
7 logosm.jpg GRAPHIC 10403
  Complete submission text file 0001437749-24-030299.txt   192481

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA crvo-20240926.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crvo-20240926_def.xml EX-101.DEF 11424
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE crvo-20240926_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crvo-20240926_pre.xml EX-101.PRE 11584
18 EXTRACTED XBRL INSTANCE DOCUMENT crvo20240930_8k_htm.xml XML 2821
Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116
Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116 (617) 744-4400
CervoMed Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 241341368
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)